546 related articles for article (PubMed ID: 16821203)
1. [Lowered ghrelin levels in acromegaly—normalization after treatment].
Kozakowski J; Rabijewski M; Zgliczyński W
Endokrynol Pol; 2005; 56(6):862-70. PubMed ID: 16821203
[TBL] [Abstract][Full Text] [Related]
2. Ghrelin test for the assessment of GH status in successfully treated patients with acromegaly.
Pekic S; Doknic M; Miljic D; Joksimovic M; Glodic J; Djurovic M; Dieguez C; Casanueva F; Popovic V
Eur J Endocrinol; 2006 May; 154(5):659-66. PubMed ID: 16645012
[TBL] [Abstract][Full Text] [Related]
3. Effect of oral glucose on acylated and total ghrelin secretion in acromegalic patients.
Isidro ML; Nemina R; Garcia-Buela J; Sangiao-Alvarellos S; Cordido F
Neuro Endocrinol Lett; 2007 Oct; 28(5):596-603. PubMed ID: 17984943
[TBL] [Abstract][Full Text] [Related]
4. Acylated ghrelin secretion is acutely suppressed by oral glucose load or insulin-induced hypoglycemia independently of basal growth hormone secretion in humans.
Kim SW; Kim KW; Shin CS; Park DJ; Park KS; Cho BY; Lee HK; Kim SY
Horm Res; 2007; 67(5):211-9. PubMed ID: 17114888
[TBL] [Abstract][Full Text] [Related]
5. Perioperative plasma active and total ghrelin levels are reduced in acromegaly when compared with in nonfunctioning pituitary tumours even after normalization of serum GH.
Kawamata T; Inui A; Hosoda H; Kangawa K; Hori T
Clin Endocrinol (Oxf); 2007 Jul; 67(1):140-4. PubMed ID: 17466003
[TBL] [Abstract][Full Text] [Related]
6. Does partial surgical tumour removal influence the response to octreotide-LAR in acromegalic patients previously resistant to the somatostatin analogue?
Jallad RS; Musolino NR; Kodaira S; Cescato VA; Bronstein MD
Clin Endocrinol (Oxf); 2007 Aug; 67(2):310-5. PubMed ID: 17555503
[TBL] [Abstract][Full Text] [Related]
7. Ghrelin - growth hormone releasing and orexigenic hormone in men declines with age, insulin and with decrease in testosterone concentration.
Kozakowski J; Rabijewski M; Zgliczyński W
Neuro Endocrinol Lett; 2008 Feb; 29(1):100-6. PubMed ID: 18283260
[TBL] [Abstract][Full Text] [Related]
8. [Effect of recombinant human growth hormone on glucose metabolism in children with growth hormone deficiency].
Liang L; Zou CC; Li Y; Wang CL; Jiang YJ; Dong GP; Fu JF; Wang XM
Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):657-61. PubMed ID: 17217656
[TBL] [Abstract][Full Text] [Related]
9. Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly.
Colao A; Pivonello R; Cavallo LM; Gaccione M; Auriemma RS; Esposito F; Cappabianca P; Lombardi G
Clin Endocrinol (Oxf); 2006 Aug; 65(2):250-6. PubMed ID: 16886969
[TBL] [Abstract][Full Text] [Related]
10. Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.
Popovic V; Doknic M; Maric N; Pekic S; Damjanovic A; Miljic D; Popovic S; Miljic N; Djurovic M; Jasovic-Gasic M; Dieguez C; Casanueva FF
Neuroendocrinology; 2007; 85(4):249-56. PubMed ID: 17570902
[TBL] [Abstract][Full Text] [Related]
11. Forty month follow-up of persistent and difficultly controlled acromegalic patients treated with depot long acting somatostatin analog octreotide.
Yetkin DO; Boysan SN; Tiryakioglu O; Yalin AS; Kadioglu P
Endocr J; 2007 Jun; 54(3):459-64. PubMed ID: 17495423
[TBL] [Abstract][Full Text] [Related]
12. Ghrelin concentrations in acromegalic patients in relation to the administered therapy.
Wasko R; Jaskula M; Komarowska H; Zamyslowska H; Sowinski J; Waligorska-Stachura J
Neuro Endocrinol Lett; 2006; 27(1-2):162-8. PubMed ID: 16670671
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone and ghrelin secretion in severely obese women before and after bariatric surgery.
Valera Mora ME; Manco M; Capristo E; Guidone C; Iaconelli A; Gniuli D; Rosa G; Calvani M; Mingrone G
Obesity (Silver Spring); 2007 Aug; 15(8):2012-8. PubMed ID: 17712119
[TBL] [Abstract][Full Text] [Related]
14. Medical treatment of acromegaly: comorbidities and their reversibility by somatostatin analogs.
Tolis G; Angelopoulos NG; Katounda E; Rombopoulos G; Kaltzidou V; Kaltsas D; Protonotariou A; Lytras A
Neuroendocrinology; 2006; 83(3-4):249-57. PubMed ID: 17047390
[TBL] [Abstract][Full Text] [Related]
15. Adequacy of current postglucose GH nadir limit (< 1 microg/l) to define long-lasting remission of acromegalic disease.
Ronchi CL; Arosio M; Rizzo E; Lania AG; Beck-Peccoz P; Spada A
Clin Endocrinol (Oxf); 2007 Apr; 66(4):538-42. PubMed ID: 17371472
[TBL] [Abstract][Full Text] [Related]
16. Effect of chronic treatment with octreotide nasal powder on serum levels of growth hormone, insulin-like growth factor I, insulin-like growth factor binding proteins 1 and 3 in acromegalic patients.
Invitti C; Fatti L; Camboni MG; Porcu L; Danesi L; Delitala G; Cavagnini F
J Endocrinol Invest; 1996 Sep; 19(8):548-55. PubMed ID: 8905479
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance and insulin secretion in non-diabetic acromegalic patients.
Coculescu M; Niculescu D; Lichiardopol R; Purice M
Exp Clin Endocrinol Diabetes; 2007 May; 115(5):308-16. PubMed ID: 17516294
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone binding protein and growth hormone availability in acromegalic patients treated with long-acting octreotide (Sandostatin-LAR).
Fisker S; Kaal A; Montini M; Pedroncelli A; Pagani G; Orskov H
Eur J Endocrinol; 1997 Jan; 136(1):61-6. PubMed ID: 9037128
[TBL] [Abstract][Full Text] [Related]
19. Acromegaly.
Scacchi M; Cavagnini F
Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of ghrelin on insulin secretion and glucose disposal rate in gastrectomized patients.
Damjanovic SS; Lalic NM; Pesko PM; Petakov MS; Jotic A; Miljic D; Lalic KS; Lukic L; Djurovic M; Djukic VB
J Clin Endocrinol Metab; 2006 Jul; 91(7):2574-81. PubMed ID: 16621911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]